What Is an FDA Import Alert?
An FDA Import Alert is an official communication from the FDA to its field staff and to U.S. Customs & Border Protection (CBP) that a product, manufacturer, or country has a history of violating FDA regulations. When an import alert is in effect, the FDA can detain shipments from the named manufacturer without physical examination — a process called "detention without physical examination" (DWPE).
Import alerts are publicly available on the FDA's website and are visible to your U.S. buyers, importers, and customs brokers. Being on an import alert is extremely damaging to business relationships.
What Triggers an Import Alert?
The FDA issues import alerts for a wide range of violations, including:
- Unregistered facility — Shipping to the U.S. from a facility not registered with the FDA
- Failed FDA inspection — Inspection findings of significant GMP violations
- Contamination or adulteration — Product samples testing positive for pathogens, pesticides, undeclared ingredients, or contaminants
- Misbranding — Labels that violate FDA requirements
- Unapproved drugs or devices — Marketing products that require FDA clearance without it
- Refusal of inspection — Refusing an FDA facility inspection
- Repeated violations — Multiple shipments refused at the border
Types of Import Alerts
Company-Specific Import Alert
Names a specific manufacturer or shipper. Only products from that specific company are subject to DWPE. This is the most common type for individual facility violations.
Country-Wide Import Alert
Covers all shipments of a specific product type from an entire country when the FDA has found widespread problems. For example, there have been country-wide import alerts for shrimp from specific countries due to antibiotic residues.
Product-Specific Import Alert
Covers a specific type of product from all sources when there is a systemic safety concern, such as adulterated herbal supplements or contaminated spices.
How to Get Removed from an Import Alert
Removal from an import alert (called "getting off the red list") requires demonstrating to the FDA that the underlying violation has been corrected. The process varies by alert type but generally involves:
- 1Understand the specific violation Obtain the full text of the import alert from the FDA's website. Understand exactly what triggered it — the specific regulation violated and the evidence the FDA relied upon.
- 2Conduct a root cause analysis Identify not just the surface issue but the underlying cause. For GMP violations, this means a systematic review of your quality system. For contamination, it means identifying the source.
- 3Implement corrective actions (CAPA) Document all corrective actions taken. These must be substantive and verifiable — not just promises of improvement.
- 4Submit a Corrective Action Plan (CAP) to FDA Prepare a comprehensive written CAP addressed to the FDA district that oversees your region. Include evidence of all corrective actions taken.
- 5Arrange for an FDA follow-up inspection (if required) Many import alerts for GMP violations require a successful follow-up inspection before removal. For foreign facilities, this may be a foreign inspection or may be satisfied through third-party audit programs.
- 6Submit sample analysis results (if applicable) For contamination-based alerts, submitting a series of passing laboratory analyses of your product may support removal.
Prevention: How to Avoid Import Alerts
- Maintain valid FDA facility registration at all times
- Never refuse an FDA inspection
- Implement and maintain robust GMP systems
- Test products before export to catch contamination issues early
- Ensure labels are fully compliant with FDA requirements
- Respond promptly and cooperatively to any FDA inquiries